Table 1.
Patient demographics and preoperative demographics by race.
| Black (n = 20) | White (n = 41) | p-value | |
|---|---|---|---|
| Age (years) | 55.5 (36.0-73.0) | 55.3 (23.0-75.0) | 0.9540 |
| Sex | 0.9416 | ||
| Female | 12 (60.0%) | 25 (61.0%) | |
| Male | 8 (40.0%) | 16 (39.0%) | |
| BMI (kg/m2) | 31.9 (21.8-53.9) | 30.0 (18.4-57.8) | 0.3483 |
| Insurance | 0.9354 | ||
| Private | 11 (55.0%) | 23 (56.1%) | |
| Government | 9 (45.0%) | 18 (43.9%) | |
| Household Income (USD, mean) |
53,719 (27,063-92,069) | 69,294 (36,379-107,321) | 0.0011 |
| Distance Traveled (miles, mean) |
34.9 (3.0-102.0) | 63.0 (4.1-822.0) | 0.3596 |
| Comorbidities | |||
| Hypertension | 14 (70.0%) | 16 (39.0%) | 0.0231 |
| Coronary artery disease | 0 (0.0%) | 5 (12.2%) | 0.1620 |
| Diabetes mellitus | 4 (20.0%) | 10 (24.4%) | 0.7019 |
| COPD | 1 (5.0%) | 1 (2.4%) | 1.0000 |
| Chronic kidney disease | 1 (5.0%) | 0 (0.0%) | 0.3279 |
| Current Smoker | 2 (10.0%) | 2 (4.9%) | 0.5915 |
| ASA Score | 0.9795 | ||
| 1 | 0 (0.0%) | 0 (0.0%) | |
| 2 | 3 (15.0%) | 7 (17.1%) | |
| 3 | 16 (80.0%) | 32 (78.1%) | |
| 4 | 1 (5.0%) | 2 (4.9%) | |
| 5 | 0 (0.0%) | 0 (0.0%) | |
| ECOG-PS | 0.0441 | ||
| 0 | 11 (55.0%) | 34 (82.9%) | |
| 1 | 8 (40.0%) | 7 (17.1%) | |
| 2 | 1 (5.0%) | 0 (0.0%) | |
| Primary Cancer Type | 0.8703 | ||
| Appendiceal | 6 (30.0%) | 10 (24.4%) | |
| Colorectal | 7 (35.0%) | 16 (39.0%) | |
| Esophageal | 0 (0.0%) | 1 (2.4%) | |
| Gastric | 1 (5.0%) | 1 (2.4%) | |
| Ovarian/Fallopian | 2 (10.0%) | 8 (19.5%) | |
| Small bowel | 1 (5.0%) | 2 (4.9%) | |
| Other | 3 (15.0%) | 3 (7.3%) | |
| Neoadjuvant Chemotherapy | 13 (65.0%) | 25 (61.0%) | 0.7608 |
| Preoperative Albumin | 4.4 (3.1-4.8) | 4.2 (3.6-5.0) | 0.1701 |